Company intelligence / Profile preview

Highfly

Seongnam-si, Gyeonggi-do, South Korea

Ownership: Private
Development stage: Other

Overview

Highfly Co., Ltd. is a South Korean pharmaceutical and biotechnology company specializing in the development, manufacturing, and distribution of Active Pharmaceutical Ingredients (APIs). With over 25 years of experience in the raw materials business, the company provides a comprehensive range of APIs produced through chemical synthesis and fermentation processes. Highfly serves as a strategic partner for both domestic and international pharmaceutical manufacturers, offering high-quality ingredients for various therapeutic applications. The company also operates a dedicated R&D center in Seongnam-si, focusing on the innovation of synthesis technologies and the expansion of its bio-healthcare product portfolio.

Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Highfly.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Highfly.

Explore the full profile